Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma

Table 4 Cytoplasmic REDD1 expression and OS

REDD1 expression	No. of patients	Median survival months (95% CI)	Survival rate (95% CI)			χ2	P-value
REDD1 expression	No. of patients	Median survival months (95% CI)	36-months	60-months	120-months	χ2	P-value
Low expression	148	125.000(113.914,137.086)	0.76(0.671, 0.828)	0.71(0.007,0.976)	0.33(0.217,0.448)	40.115	< 0.001
High expression	81	32.700(16.536,48.864)	0.41(0.273,0.542)	0.24(0.119,0.384)	0.08(0.017,0.211)

ISSN: 1746-1596